Skip to main content

Advertisement

Log in

Is an FDG-PET Scan the New Imaging Standard for Colon Cancer?

  • Editorials
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Libutti SK, Alexander HR, Choyke P, et al. A Prospective Study of 2-[18F] Fluoro-2-Deoxy-d-glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels. Ann Surg Oncol 8: 779–86.

  2. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Sem Nucl Med 2000; 30: 150–85.

    Google Scholar 

  3. Willkomm P, Bender H, Bangard M, et al. FDG-PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657–63.

    Google Scholar 

  4. Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319–23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard S. Swanson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swanson, R.S. Is an FDG-PET Scan the New Imaging Standard for Colon Cancer?. Ann Surg Oncol 8, 752–753 (2001). https://doi.org/10.1007/s10434-001-0752-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0752-7

Navigation